November 29, 2022
| Trial | CONCORDE |
|---|---|
| Cancer Type | Lung Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | A platform study of DNA damage response inhibitors in combination with conventional radiotherapy in non small cell lung cancer |
 |
Click Here to view Cancer Research UK trial summary |